Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Rules and Regulations 16269 

invited to attend the meetings and 

participate in Board deliberations. Like 

all Board meetings, the March 18, 2006, 

meeting was a public meeting and all 

entities, both large and small, were able 

to express their views on this issue. 

Finally, interested persons were invited 

to submit information on the regulatory 

and informational impacts of this action 

on small businesses. 

An interim final rule concerning this 

action was published in the Federal 

Register on December 22, 2006. Copies 

of the rule were mailed by the Board’s 

staff to all Board members and potato 

handlers. In addition, the rule was made 

available through the Internet by USDA 

and the Office of the Federal Register. 

The interim final rule provided for a 60- 

day comment period which ended 

February 20, 2007. Two comments were 

received, both of which were in support 

of the change. 

A small business guide on complying 

with fruit, vegetable, and specialty crop 

marketing agreements and orders may 

be viewed at the following Web site: 

http://www.ams.usda.gov/fv/moab.html. 

Any questions about the compliance 

guide should be sent to Jay Guerber at 

the previously mentioned address in the 

FOR FURTHER INFORMATION CONTACT

section. 

After consideration of all relevant 

material presented, including the 

Board’s recommendation, and other 

information, the interim final rule as 

published in the Federal Register (71 

FR 76899, December 22, 2006), is 

adopted, as a final rule, without change. 

List of Subjects in 7 CFR Part 1207 

Advertising, Agricultural research, 

Imports, Potatoes, Reporting and 

recordkeeping requirements. 

PART 1207—POTATO RESEARCH 

AND PROMOTION PLAN 

■ Accordingly, the interim final rule 

amending 7 CFR part 1207 which was 

published at 71 FR 76899 on December 

22, 2006, is adopted as a final rule 

without change. 

Dated: March 29, 2007. 

Lloyd C. Day, 

Administrator, Agricultural Marketing 

Service. 

[FR Doc. E7–6274 Filed 4–3–07; 8:45 am] 

BILLING CODE 3410–02–P 

COMMODITY FUTURES TRADING 

COMMISSION 

17 CFR Parts 140 and 145 

Corrections to Regional Office 

Information 

AGENCY: Commodity Futures Trading 

Commission. 

ACTION: Final rule. 

SUMMARY: The Commodity Futures 

Trading Commission (‘‘Commission’’) is 

amending its regulations to delete 

references to the Minneapolis office, 

which was closed as of December 31, 

2006, and to update the address of the 

Southwestern regional office. 

DATES: Effective April 4, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Stacy Yochum, Deputy Executive 

Director, at (202) 418–5157, Office of the 

Executive Director, Commodity Futures 

Trading Commission, Three Lafayette 

Centre, 1155 21st St., NW., Washington 

DC 20581; e-mail syochum@cftc.gov. 

SUPPLEMENTARY INFORMATION: 

Commission Rule 140.2 describes the 

organization and location of the 

Commission’s regional offices in New 

York, Chicago, and Kansas City (the 

Eastern, Central, and Southwestern 

regional offices). As of December 31, 

2006, the Commission closed the 

Minneapolis sub-office of the 

Southwestern regional office. In 

addition, the Kansas City office moved 

to a new location in September 2004. 

The Commission is therefore amending 

Rule 140.2 to delete the reference to the 

Minneapolis office and to reflect the 

new address of the Southwestern 

regional office. There is no change to the 

states covered by the Southwestern 

region. The Commission is also 

replacing the term ‘‘regional director’’

with ‘‘regional coordinator’’ to reflect 

the term used by the Commission to 

describe the head of each regional 

office. 

In addition, the Commission is 

amending the list of addresses provided 

in Rule 145.6, which instructs members 

of the public on where to direct requests 

for public records, to remove the 

reference to the Minneapolis office and 

to update the Kansas City address. 

List of Subjects 

17 CFR Part 140 

Authority delegations (Government 

agencies), Organization and functions 

(Government agencies). 

17 CFR Part 145 

Confidential business information, 

Freedom of Information. 

■ Accordingly, 17 CFR parts 140 and 

145 are amended as follows: 

PART 140—ORGANIZATION, 

FUNCTIONS, AND PROCEDURES OF 

THE COMMISSION 

■ 1. The authority citation for part 140 

continues to read as follows: 

Authority: 7 U.S.C. 2 and 12a. 

■ 2. Section 140.2 is amended by 

revising the section heading, the 

introductory text, and paragraph (c) to 

read as follows: 

§ 140.2 Regional Office-Regional 

Coordinators. 

Each of the Regional offices described 

herein functions as set forth in this 

section under the direction of a Regional 

Coordinator who, as a collateral duty, 

oversees the administration of the office 

and represents the Commission in 

negotiations with employee union 

officials and in interactions with 

external parties. Each regional office has 

delegated authority for the enforcement 

of the Act and administration of the 

programs of the Commission in the 

particular regions. 

* * * * * 

(c) The Southwestern Regional Office 

is located at Two Emanuel Cleaver II 

Blvd., Suite 300, Kansas City, Missouri 

64112, and is responsible for 

enforcement of the Act and 

administration of the programs of the 

Commission in the States of Alaska, 

Arizona, Arkansas, California, Colorado, 

Hawaii, Idaho, Iowa, Kansas, Louisiana, 

Minnesota, Missouri, Montana, 

Nebraska, Nevada, New Mexico, North 

Dakota, Oklahoma, Oregon, South 

Dakota, Texas, Utah, Washington, and 

Wyoming. 

PART 145—COMMISSION RECORDS 

AND INFORMATION 

■ 3. The authority citation for part 145 

continues to read as follows: 

Authority: Pub. L. 99–570, 100 Stat. 3207; 

Pub. L. 89–554, 80 Stat. 54; Pub. L. 98–502, 

88 Stat. 1561–1564 (5 U.S.C. 552); Sec. 

101(a), Pub. L. 93–463, 88 Stat. 1389 (5 

U.S.C. 4a(j)); unless otherwise noted. 

■ 4. Section 145.6 is amended by 

revising paragraph (a) to read as follows: 

§ 145.6 Commission office to contact for 

assistance; registration records available. 

(a) Whenever this part directs that a 

request be directed to the Assistant 

Secretary of the Commission for FOI, 

Privacy and Sunshine Acts Compliance, 

the request shall be made in writing and 

shall be addressed or otherwise directed 

to the Office of the Secretariat, 

Commodity Futures Trading 


cprice-sewell on PROD1PC61 with RULES
16270 Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Rules and Regulations 

Commission, Three Lafayette Centre, 

1155 21st Street, NW., Washington, DC 

20581. Requests for public records 

directed to a regional office of the 

Commission pursuant to § 145.2 should 

be sent to: 

Commodity Futures Trading 

Commission, 140 Broadway, New York, 

New York 10005, Telephone: (646) 746–

9700. 

Commodity Futures Trading 

Commission, 525 West Monroe Street, 

Suite 1100 North, Chicago, Illinois 

60661, Telephone: (312) 596–0700. 

Commodity Futures Trading 

Commission, Two Emanuel Cleaver II 

Blvd., Suite 300, Kansas City, Missouri 

64112, Telephone: (816) 960–7700. 

* * * * * 

Dated: March 29, 2007. 

By the Commission. 

Eileen A. Donovan, 

Acting Secretary of the Commission. 

[FR Doc. E7–6190 Filed 4–3–07; 8:45 am] 

BILLING CODE 6351–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 520 

Oral Dosage Form New Animal Drugs; 

Praziquantel and Pyrantel 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect 

approval of an original new animal drug 

application (NADA) filed by Virbac AH, 

Inc. The NADA provides for use of 

chewable tablets containing 

praziquantel and pyrantel pamoate in 

dogs and puppies for the treatment and 

control of various internal parasites. 

DATES: This rule is effective April 4, 

2007. 

FOR FURTHER INFORMATION CONTACT: 

Melanie R. Berson, Center for Veterinary 

Medicine (HFV–110), Food and Drug 

Administration, 7500 Standish Pl., 

Rockville, MD 20855, 301–827–7540, email: melanie.berson@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Virbac 

AH, Inc., 3200 Meacham Blvd., Ft. 

Worth, TX 76137, filed NADA 141–261 

for WORMXPLUS (praziquantel and 

pyrantel pamoate) Flavored Chewables 

and VIRBANTEL (praziquantel and 

pyrantel pamoate) Flavored Chewables 

that provides for their use in dogs and 

puppies for the treatment and control of 

various internal parasites. The NADA is 

approved as of March 13, 2007, and 21 

CFR 520.1871 is amended to reflect the 

approval. 

In accordance with the freedom of 

information provisions of 21 CFR part 

20 and 21 CFR 514.11(e)(2)(ii), a 

summary of safety and effectiveness 

data and information submitted to 

support approval of this application 

may be seen in the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852, between 9 

a.m. and 4 p.m., Monday through 

Friday. 

Under section 512(c)(2)(F)(ii) of the 

Federal Food, Drug, and Cosmetic Act 

(the act) (21 U.S.C. 360b(c)(2)(F)(ii)), 

this approval qualifies for 3 years of 

marketing exclusivity beginning March 

13, 2007. 

FDA has determined under 21 CFR 

25.33(d)(1) that this action is of a type 

that does not individually or 

cumulatively have a significant effect on 

the human environment. Therefore, 

neither an environmental assessment 

nor an environmental impact statement 

is required. 

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808. 

List of Subjects in 21 CFR Part 520 

Animal drugs. 

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to 

the Center for Veterinary Medicine, 21 

CFR part 520 is amended as follows: 

PART 520—ORAL DOSAGE FORM 

NEW ANIMAL DRUGS 

■ 1. The authority citation for 21 CFR 

part 520 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 2. Amend § 520.1871 as follows: 

■ a. Revise the section heading and 

paragraphs (a) and (b); 

■ b. Redesignate paragraph (c) as 

paragraph (d) and add new paragraph 

(c); and 

■ c. Revise newly redesignated 

paragraphs (d)(1)(i), (d)(1)(iii), and 

(d)(2). 

The revisions, redesignation, and 

addition read as follows: 

§ 520.1871 Praziquantel and pyrantel. 

(a) Specifications—(1) Each tablet 

contains 18.2 milligrams (mg) 

praziquantel and 72.6 mg pyrantel (as 

pyrantel pamoate). 

(2) Each chewable tablet contains 30 

mg praziquantel and 30 mg pyrantel 

pamoate or 114 mg praziquantel and 

114 mg pyrantel pamoate. 

(b) Sponsors. See sponsors in 

§ 510.600(c) for use as in paragraph (d) 

of this chapter. 

(1) See No. 000859 for use of tablet 

described in paragraph (a)(1) of this 

section for use as in paragraph (d)(1) of 

this section. 

(2) See No. 051311 for use of tablets 

described in paragraph (a)(2) of this 

section for use as in paragraph (d)(2) of 

this section. 

(c) Special considerations. See 

§ 500.25 of this chapter. 

(d) * * * 

(1) * * * 

(i) Dosage. 1.5 to 1.9 pounds, 1/4 

tablet; 2 to 3 pounds, 1/2 tablet; 4 to 8 

pounds, 1 tablet; 9 to 12 pounds, 1 1/ 

2 tablets; 13 to 16 pounds, 2 tablets. If 

reinfection occurs, treatment may be 

repeated. 

* * * * * 

(iii) Limitations. Not for use in kittens 

less than 1 month of age or weighing 

less than 1.5 pounds. May be given 

directly by mouth or in a small amount 

of food. Do not withhold food prior to 

or after treatment. Consult your 

veterinarian before giving to sick or 

pregnant animals. 

(2) Dogs—(i) Amount. Administer a 

minimum dose of 5 mg praziquantel and 

5 mg pyrantel pamoate per kilogram 

body weight (2.27 mg praziquantel and 

2.27 mg pyrantel pamoate per pound 

body weight) according to the dosing 

tables on labeling. 

(ii) Indications for use. For the 

treatment and control of roundworms 

(Toxocara canis and Toxascaris 

leonina), hookworms (Ancylostoma 

caninum, Ancylostoma braziliense, and 

Uncinaria stenocephala), and 

tapeworms (Dipylidium caninum and 

Taenia pisiformis) in dogs and puppies. 

Dated: March 26, 2007. 

Stephen F. Sundlof, 

Director, Center for Veterinary Medicine. 

[FR Doc. E7–6181 Filed 4–3–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 558 

New Animal Drugs for Use in Animal 

Feeds; Melengestrol and Lasalocid 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule. 


cprice-sewell on PROD1PC61 with RULES